Table 1.
Characteristics of patients with oropharyngeal cancer (n = 357) from the ARTSCAN trial as well as for study cohorts 1 (n = 232) and 2 (n = 203)
| Patients with oropharyngeal cancer, n (%) | Study cohort 1, n (%) | Study cohort 2, n (%) | |
|---|---|---|---|
|
Age |
|
|
|
|
Median (min, max) |
58 (32, 86) |
57 (32, 86) |
57 (32, 86) |
| <65 years |
275 (77.0) |
184 (79.3) |
160 (78.8) |
| ≥65 years |
82 (23.0) |
48 (20.7) |
43 (21.2) |
|
Sex |
|
|
|
| Male |
267 (74.8) |
173 (74.6) |
154 (75.9) |
| Female |
90 (25.2) |
59 (25.4) |
49 (24.1) |
|
Clinical stage |
|
|
|
| I |
10 (2.8) |
8 (3.4) |
9 (4.4) |
| II |
20 (5.6) |
16 (6.9) |
13 (6.4) |
| III |
84 (23.5) |
54 (23.3) |
41 (20.2) |
| IV |
243 (68.1) |
154 (66.4) |
140 (69.0) |
|
Surgery |
|
|
|
| Yes |
166 (46.5) |
103 (44.4) |
106 (52.2) |
| No |
191 (53.5) |
129 (55.6) |
97 (47.8) |
|
Conventional fractionation |
178 (49.9) |
117 (50.4) |
106 (52.2) |
|
Accelerated fractionation |
179 (50.1) |
115 (49.6) |
97 (47.8) |
| Number of patients | n = 357 | n = 232 | n = 203 |